Clinical Trials Directory

Trials / Completed

CompletedNCT03786276

Virtual Reality- Working Memory Retraining

Effects of Active Virtual Reality Working Memory Retraining on Heavy Drinking Veterans With Mild Traumatic Brain Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will establish the acceptability and feasibility of enrolling and retaining heavy drinking Veterans with mild traumatic brain injury (mTBI) in an 8-week, randomized cross-over design trial of active VR working memory retraining (WMR). This study will also seek to establish the efficacy of active VR-WMR to increase performance in executive function.

Detailed description

The investigators will employ a physically active VR working memory retraining (VR-WMR) regimen utilizing components of Blue Goji VR Active Gaming. The synthesis of physical activity and an enriched VR environment is expected to yield superior working memory training stemming from greater neurological activation. This enhanced working memory training task will result in greater motivation to engage and complete a training regimen, thus fostering greater improvements in executive function than traditional working memory training tasks; ultimately resulting in increased self-control over alcohol use and other high-risk behaviors.

Conditions

Interventions

TypeNameDescription
BEHAVIORALVR-WMR-OnlyParticipants will spend up to 30 minutes in a VR-WMR environment during each training session.
BEHAVIORALExercise-onlyParticipants will ride a stationary recumbent bicycle for up to 30 minutes during each training session.
BEHAVIORALActive VR-WMRParticipants will spend up to 30 minutes in a VR-WMR environment while riding a stationary, recumbent bicycle during each training session.

Timeline

Start date
2019-02-01
Primary completion
2020-03-31
Completion
2020-03-31
First posted
2018-12-26
Last updated
2020-05-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03786276. Inclusion in this directory is not an endorsement.